Balance Sheet

SANDU PHARMACEUTICALS LTD.

NSE : NABSE : 524703ISIN CODE : INE751D01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE57.39-0.26 (-0.45 %)
PREV CLOSE ( ) 57.65
OPEN PRICE ( ) 58.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3565
TODAY'S LOW / HIGH ( )56.26 59.40
52 WK LOW / HIGH ( ) 4985
NSE
This Company is not listed in NSE
Select year
( in Million)
ParticularsMar2023
EQUITY AND LIABILITIES
Share Capital96.61
    Equity - Authorised100.00
    Equity - Issued96.61
    Equity Paid Up96.61
    Equity Shares Forfeited0.00
    Adjustments to Equity0.00
    Preference Capital Paid Up0.00
    Face Value10.00
Share Warrants & Outstandings0.00
Total Reserves295.80
    Securities Premium27.58
    Capital Reserves0.00
    Profit & Loss Account Balance76.92
    General Reserves95.03
    Other Reserves96.27
Reserve excluding Revaluation Reserve207.38
Revaluation reserve88.42
Shareholder's Funds392.41
Minority Interest0.00
Long-Term Borrowings0.00
Secured Loans0.00
    Non Convertible Debentures0.00
    Converible Debentures & Bonds0.00
    Packing Credit - Bank0.00
    Inter Corporate & Security Deposit0.00
    Term Loans - Banks0.00
    Term Loans - Institutions0.00
    Other Secured0.00
Unsecured Loans0.00
    Fixed Deposits - Public0.00
    Loans and advances from subsidiaries0.00
    Inter Corporate Deposits (Unsecured)0.00
    Foreign Currency Convertible Notes0.00
    Long Term Loan in Foreign Currency0.00
    Loans - Banks0.00
    Loans - Govt.0.00
    Loans - Others0.00
    Other Unsecured Loan0.00
Deferred Tax Assets / Liabilities10.42
    Deferred Tax Assets0.14
    Deferred Tax Liability10.56
Other Long Term Liabilities0.00
Long Term Trade Payables0.00
Long Term Provisions0.00
Total Non-Current Liabilities10.42
Current Liabilities
Trade Payables83.98
    Sundry Creditors83.98
    Acceptances0.00
    Due to Subsidiaries- Trade Payables0.00
Other Current Liabilities14.09
    Bank Overdraft / Short term credit0.00
    Advances received from customers3.92
    Interest Accrued But Not Due0.00
    Share Application Money0.00
    Current maturity of Debentures & Bonds0.00
    Current maturity - Others0.00
    Other Liabilities10.17
Short Term Borrowings0.00
    Secured ST Loans repayable on Demands0.00
    Working Capital Loans- Sec0.00
    Buyers Credits - Unsec0.00
    Commercial Borrowings- Unsec0.00
    Other Unsecured Loans0.00
Short Term Provisions40.77
    Proposed Equity Dividend0.00
    Provision for Corporate Dividend Tax0.00
    Provision for Tax13.25
    Provision for post retirement benefits14.67
    Preference Dividend0.00
    Other Provisions12.85
Total Current Liabilities138.83
Total Liabilities541.66
ASSETS
Gross Block275.07
Less: Accumulated Depreciation108.90
Less: Impairment of Assets0.00
Net Block166.17
Lease Adjustment A/c0.00
Capital Work in Progress4.20
Non Current Investments96.46
Long Term Investment96.46
    Quoted96.45
    Unquoted0.01
Long Term Loans & Advances0.00
Other Non Current Assets19.39
Total Non-Current Assets286.21
Current Assets Loans & Advances
Currents Investments0.00
    Quoted0.00
    Unquoted0.00
Inventories143.26
    Raw Materials13.20
    Work-in Progress13.60
    Finished Goods41.27
    Packing Materials0.00
    Stores  and Spare0.00
    Other Inventory75.19
Sundry Debtors47.92
    Debtors more than Six months13.74
    Debtors Others34.78
Cash and Bank22.96
    Cash in hand0.36
    Balances at Bank22.60
    Other cash and bank balances0.00
Other Current Assets3.93
    Interest accrued on Investments1.40
    Interest accrued on Debentures0.00
    Deposits with Government0.00
    Interest accrued and or due on loans0.00
    Prepaid Expenses0.76
    Other current_assets1.77
Short Term Loans and Advances37.39
    Advances recoverable in cash or in kind8.28
    Advance income tax and TDS0.00
    Amounts due from directors0.00
    Due From Subsidiaries0.00
    Inter corporate deposits0.00
    Corporate Deposits0.00
    Other Loans & Advances29.11
Total Current Assets255.45
Net Current Assets (Including Current Investments)116.62
Miscellaneous Expenses not written off0.00
Total Assets541.66
Contingent Liabilities33.72
Total Debt0.00
Book Value31.47
Adjusted Book Value31.47

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.